Imamura Shin | First Department Of Internal Medicine Fukui Medical University
スポンサーリンク
概要
関連著者
-
Ueda Takanori
福井大学 血液腫瘍内科学
-
Ueda T
First Department Of Internal Medicine University Of Fukui
-
Ueda Takahiro
First Department Of Internal Medicine Fukui Medical University Idarubicin Study Group
-
Imamura Shin
First Department Of Internal Medicine Fukui Medical University
-
Ueda T
Department Of Hematology And Oncology University Of Fukui
-
Ueda Takanori
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
IKEGAYA Satoshi
Division of Molecular Pathology, University of Fukui, Faculty of Medical Sciences
-
UEDA Takanori
First Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui
-
Ueda T
Department Of Urology Chiba Cancer Center
-
Iwasaki Hiromichi
Department Of Hematology And Oncology University Of Fukui
-
Ueda Takeshi
Department Of Urology Chiba University Graduate School Of Medicine
-
Yabe Aya
Department Of Molecular Biology Institute Of Gerontology Nippon Medical School
-
TSUTANI Hiroshi
Department of Hematology and Oncology, University of Fukui
-
TSUTANI Hiroshi
First Department of Internal Medicine, University of Fukui
-
IMAMURA Shin
First Department of Internal Medicine, Fukui Medical University
-
Tsutani Hiroshi
Department Of Hematology And Oncology University Of Fukui
-
Yoshida Akira
First Department Of Internal Medicine University Of Fukui
-
Yoshida A
First Department Of Internal Medicine University Of Fukui
-
Yoshida Akira
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
Yamauchi T
Department Of Hematology And Oncology University Of Fukui
-
Yamauchi Takahiro
福井大学 血液腫瘍内科学
-
YAMAUCHI Takahiro
First Department of Internal Medicine, University of Fukui
-
YOSHIDA Akira
First Department of Internal Medicine, Fukui Medical University
-
Yoshida A
Department Of Applied Biological Sciences School Of Agricultural Sciences Nagoya University
-
Yamauchi Takahiro
First Department Of Internal Medicine Fukui Medical University
-
Kuraishi Yasunobu
国立金沢病院
-
Kuraishi Yasunobu
Idarubicin Study Group Internal Medicine Iii Jikei University School Of Medicine
-
IWASAKI Hiromichi
Division of Hematology and Cardiology, University of Fukui, Faculty of Medical Sciences
-
KAWAI Yasukazu
First Department of Internal Medicine, Fukui Medical University
-
FUKUSHIMA Toshihiro
Internal Medicine, National Kanazawa Hospital
-
URASAKI Yoshimasa
First Department of Internal Medicine, Fukui Medical University
-
FUKUSHIMA Toshihiro
First Department of Internal Medicine, Fukui Medical University
-
IWASAKI Hiromichi
First Department of Internal Medicine, Fukui Medical University
-
Naiki Hironobu
Second Department Of Pathology University Of Fukui
-
Urasaki Yoshimasa
First Department Of Internal Medicine University Of Fukui
-
Kawai Yasukazu
Department Of Hematology And Oncology University Of Fukui
-
Kawai Yasukazu
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
Fukushima T
Internal Medicine National Kanazawa Hospital
-
KISHI Shinji
First Division, Department of Pathology, Kobe University School of Medicine
-
Kishi Shinji
福井大学 医学部第一内科
-
Kishi S
First Department Of Internal Medicine Fukui Medical University
-
IKEGAYA Satoshi
Second Department of Pathology, Fukui Medical University
-
GOTO Nobuyuki
Department of Hospital Pharmacy, Fukui Medical University
-
MASADA Mikio
Department of Hospital Pharmacy, Fukui Medical University
-
Nakamura Toru
福井医科大学 第1内科
-
Nakayama Takashi
First Department Of Internal Medicine Fukui Medical University
-
Goto N
Department Of Hospital Pharmacy Fukui Medical University
-
Ueda T
First Department Of Internal Medicine Fukui Medical School
-
Goto Nobuyuki
Department Of Hospital Pharmacy Fukui Medical University
-
Kishi Shinji
First Department Of Internal Medicine University Of Fukui
-
Masada Mikio
Department Of Hospital Pharmacy Fukui Medical University
-
Ikegaya Satoshi
Division Of Molecular Pathology University Of Fukui Faculty Of Medical Sciences
-
Goto Nobuyuki
Department of Drug Informatics, Faculty of Pharmacy, Meijo University
-
NAIKI Hironobu
Second Department of Pathology, University of Fukui
-
INAI Kunihiro
Divisions of Molecular Pathology, Department of Pathological Sciences, Faculty of Medical Sciences,
-
UEDA Takanori
Divisions of Hematology and Oncology, Department of General Medicine, Faculty of Medical Sciences, U
-
TAKIMOTO Nobuo
Division of Molecular Pathology, Department of Pathological Sciences, Faculty of Medical Sciences, U
-
IMAMURA Yoshiaki
Division of Surgical Pathology, Faculty of Medical Sciences, University of Fukui
-
NAIKI Hironobu
Division of Molecular Pathology, Department of Pathological Sciences, Faculty of Medical Sciences, U
-
NORIKI Sakon
Division of Tumor Pathology, Department of Pathological Sciences, Faculty of Medical Sciences, Unive
-
YAMASHITA Masanori
Division of Clinical Inspection, University of Fukui, Faculty of Medical Sciences
-
IMAMURA Yoshiaki
Diagnostic Pathology Division, University of Fukui, Faculty of Medical Sciences
-
KATO Hisataka
Division of Tumor Pathology, University of Fukui, Faculty of Medical Sciences
-
KUWATA Atsushi
First Department of Internal Medicine, University of Fukui
-
SHIRASAKI Haruhisa
First Department of Internal Medicine, Fukui Medical University
-
YAMASHITA Taro
First Department of Internal Medicine, Fukui Medical University
-
YOSHIO Nobuyuki
First Department of Internal Medicine, Fukui Medical University
-
SEO Tamami
First Department of Internal Medicine, Fukui Medical University
-
INOUE Hitoshi
First Department of Internal Medicine, Fukui Medical University
-
NAKAMURA Toru
First Department of Internal Medicine, Fukui Medical University
-
KIRIBA Chiyo
First Department of Internal Medicine, Fukui Medical University, School of Medicine
-
NAKAMURA Toru
Hayashi General Hospital
-
Shirasaki Haruhisa
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
Noriki Sakon
Division Of Tumor Pathology Department Of Pathological Sciences Faculty Of Medical Sciences Universi
-
Katoh Hisataka
Dept. Of First Pathology Fukui Medical University
-
Kato Hisataka
Division Of Tumor Pathology University Of Fukui Faculty Of Medical Sciences
-
Inai Kunihiro
Division Of Molecular Pathology Department Of Pathological Sciences Faculty Of Medical Sciences Univ
-
Takimoto Nobuo
Division Of Molecular Pathology Department Of Pathological Sciences Faculty Of Medical Sciences Univ
-
Naiki Hironobu
Division Of Molecular Pathology Department Of Pathological Sciences Faculty Of Medical Sciences Univ
-
Kuwata Atsushi
First Department Of Internal Medicine Fukui Medical University
-
Noriki Sakon
First Department Of Pathology Fukui Medical University
-
Nakamura Toru
First Department Of Internal Medicine Fukui Medical University
-
Imamura Yoshiaki
Division Of Surgical Pathology Faculty Of Medical Sciences University Of Fukui
-
Yamashita Masanori
Division Of Clinical Inspection University Of Fukui Faculty Of Medical Sciences
-
Imamura Y
Tumour Pathology Fukui University Faculty Of Medical Sciences
-
Seo Tamami
First Department Of Internal Medicine Fukui Medical University
-
Kiriba Chiyo
First Department Of Internal Medicine Fukui Medical University School Of Medicine
-
Yoshio Nobuyuki
First Department Of Internal Medicine Faculty Of Medical Sciences University Of Fukui
-
Shirasaki Haruhisa
First Department Of Internal Medicine Fukui Medical University
-
Ueda Takanori
Division Of Hematology And Oncology Faculty Of Medical Sciences University Of Fukui
-
Inoue Hitoshi
First Department Of Internal Medicine Fukui Medical University
-
Naiki Hironobu
Division Of Molecular Pathology Department Of General Medicine Faculty Of Medical Sciences University Of Fukui
著作論文
- Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies
- Esophageal Erosion as a Possible Bacterial Entry Site in an Acute Lymphoblastic Leukemia Patient with Sepsis
- Pure Red Cell Aplasia Developing into Myeloproliferation with Myelodysplasia and Subsequent Leukemia after Cyclosporin A Therapy
- Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.
- Long-term follow-up the clinical efficacy of chemotherapy for acute myeloid leukemia at a single institute
- Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.
- Latent overproductive hyperuricemia increases in patients during the intermittent phase of gouty arthritis under long-term antihyperuricemic treatment
- Esophageal erosion as a possible bacterial entry site in an acute lymphoblastic leukemia patient with sepsis